Grants
Grants listed represent those for which Johns Hopkins Infectious Diseases researchers are principal investigators.
Displaying 41 - 50 of 339 results
-
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of Ve303 for Prevention of Recurrent Clostridioides Difficile Infection: The Restorative303 Study
Date:
05/20/2025Topics:
Lead Investigators:
-
Phase 3, Randomized, Controlled, Open-label Study to Compare the Efficacy and Safety of Bemnifosbuvir-Ruzasvir Fixed dose Combination (BEM/RZR FDC) Versus Sofosbuvir-Velpatasvir Fixed-dose Combination (SOF/VEL FDC) in Subjects with Chronic Hepatitis C Virus (HCV) Infection
Date:
05/01/2025Topics:
Lead Investigators:
-
IeDEA Asia-Pacific: JHU/BJGMC cohort and substudies
Date:
05/01/2025Locations:
Lead Investigators:
-
REACH: Research Enterprise to Advance a Cure for HIV
Date:
05/01/2025Topics:
Lead Investigators:
-
Immunogenicity and Safety of Multiple-dose RSVPreF3 (Arexvy®) Vaccination among Immunocompromised Persons
Date:
04/24/2025Lead Investigators:
-
Bronchiectasis and NTM Care Center Network
Date:
04/01/2025Topics:
Lead Investigators:
-
Esx5 Secretome in TB and TB-HIV Pathogenesis and Immunity
Date:
04/01/2025Topics:
Lead Investigators:
-
FY25 Part A Health Insurance
Date:
03/01/2025Locations:
Topics:
Lead Investigators:
-
FY25 Part A Emergency Financial Assistance
Date:
03/01/2025Locations:
Topics:
Lead Investigators:
-
FY25 RWA Psychosocial Support Services
Date:
03/01/2025Locations:
Topics:
Lead Investigators: